Clinical Trial Update: A Comparative Study Between Lysine Clonixinate+Cyclobenzaprine and Caffeine+Carisoprodol+Sodium Diclofenac+Paracetamol [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing a lysine clonixinate+cyclobenzaprine combination against caffeine+carisoprodol+diclofenac sodium+paracetamol for low back pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain

Drugs mentioned

• Caffeine (caffeine)
• Carisoprodol (Carisoprodol)
• Cyclobenzaprine (cyclobenzaprine)
• DICLOFENAC SODIUM (DICLOFENAC SODIUM)
• Lysine clonixinate (lysine clonixinate)
• Paracetamol (acetaminophen)

Snippet

Sponsor: Farmoquimica S.A. | Conditions: Low Back Pain | Phase 3 | Status: UNKNOWN